Neuropeptide Y in the amygdala contributes to neuropathic pain-like behaviors in rats via the neuropeptide Y receptor type 2/mitogen-activated protein kinase axis

References

• Li Z, Li X, Chen X, et al. Emerging roles of long non-coding RNAs in neuropathic pain. Cell Prolif. 2019;52(1):e12528.
   PubMed Web of Science ®Google Scholar
• Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532–545.
   PubMed Web of Science ®Google Scholar
• Jongen JL, Hans G, Benzon HT, et al. Neuropathic pain and pharmacological treatment. Pain Pract. 2014;14(3):283–295.
   PubMed Web of Science ®Google Scholar
• Nickel FT, Seifert F, Lanz S, et al. Mechanisms of neuropathic pain. Eur Neuropsychopharmacol. 2012;22(2):81–91.
   PubMed Web of Science ®Google Scholar
• Fornasari D. Pharmacotherapy for Neuropathic Pain: a Review. Pain Ther. 2017;6(Suppl 1):25–33.
   PubMed Web of Science ®Google Scholar
• Tozaki-Saitoh H, Tsuda M. Microglia-neuron interactions in the models of neuropathic pain. Biochem Pharmacol. 2019;169:113614.
   PubMed Web of Science ®Google Scholar
• Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438(7070):1017–1021.
   PubMed Web of Science ®Google Scholar
• Corder G, Ahanonu B, Grewe BF, et al. An amygdalar neural ensemble that encodes the unpleasantness of pain. Science. 2019;363(6424):276–281.
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Zoicas I. Neuropeptide Y reduces social fear in male mice: involvement of Y1 and Y2 receptors in the dorsolateral septum and central amygdala. Int J Mol Sci. 2021;22(18):10142.
   PubMed Web of Science ®Google Scholar
• Lu C, Everhart L, Tilan J, et al. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene. 2010;29(41):5630–5642.
   PubMed Web of Science ®Google Scholar
• Sun W, Kou D, Yu Z, et al. A transcriptomic analysis of neuropathic pain in rat dorsal root Ganglia following peripheral nerve injury. Neuromolecular Med. 2020;22(2):250–263.
   PubMed Web of Science ®Google Scholar
• Malet M, Leiguarda C, Gaston G, et al. Spinal activation of the NPY Y1 receptor reduces mechanical and cold allodynia in rats with chronic constriction injury. Peptides. 2017;92:38–45.
   PubMed Web of Science ®Google Scholar
• Meister M, Tomasovic A, Banning A, et al. Mitogen-Activated Protein (MAP) kinase scaffolding proteins: a recount. Int J Mol Sci. 2013;14(3):4854–4884.
   PubMed Web of Science ®Google Scholar
• Rosmaninho-Salgado J, Cortez V, Estrada M, et al. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes. Neuropeptides. 2012;46(6):359–366.
   PubMed Web of Science ®Google Scholar
• Zhang R, Niu H, Kang X, et al. Long-term administration of neuropeptide Y in the subcutaneous infusion results in cardiac dysfunction and hypertrophy in rats. Cell Physiol Biochem. 2015;37(1):94–104.
   PubMedGoogle Scholar
• Dai WL, Yan B, Bao YN, et al. Suppression of peripheral NGF attenuates neuropathic pain induced by chronic constriction injury through the TAK1-MAPK/NF-kappaB signaling pathways. Cell Commun Signal. 2020;18(1):66.
   PubMed Web of Science ®Google Scholar
• Duan Z, Zhang J, Li J, et al. Inhibition of microRNA-155 reduces neuropathic pain during chemotherapeutic bortezomib via engagement of neuroinflammation. Front Oncol. 2020;10:416.
   PubMed Web of Science ®Google Scholar
• Mo Y, Liu B, Qiu S, et al. Down-regulation of microRNA-34c-5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve. J Neurochem. 2020;154(3):301–315.
   PubMed Web of Science ®Google Scholar
• Medeiros P, de Freitas RL, Boccella S, et al. Characterization of the sensory, affective, cognitive, biochemical, and neuronal alterations in a modified chronic constriction injury model of neuropathic pain in mice. J Neurosci Res. 2020;98(2):338–352.
   PubMed Web of Science ®Google Scholar
• Huang J, Gadotti VM, Chen L, et al. A neuronal circuit for activating descending modulation of neuropathic pain. Nat Neurosci. 2019;22(10):1659–1668.
   PubMed Web of Science ®Google Scholar
• Colangeli R, Morena M, Pittman QJ, et al. Anandamide signaling augmentation rescues amygdala synaptic function and comorbid emotional alterations in a model of epilepsy. J Neurosci. 2020;40(31):6068–6081.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhuang L, Xue Q, et al. NLRP3-mediated neuroinflammation exacerbates incisional hyperalgesia and prolongs recovery after surgery in chronic stressed rats. Pain Physician. 2021;24(7):E1099–E1108.
   PubMed Web of Science ®Google Scholar
• Gadotti VM, Zhang Z, Huang J, et al. Analgesic effects of optogenetic inhibition of basolateral amygdala inputs into the prefrontal cortex in nerve injured female mice. Mol Brain. 2019;12(1):105.
   PubMed Web of Science ®Google Scholar
• Shiels JC, Jerkovic B, Baranger AM, et al. RNA-DNA hybrids containing damaged DNA are substrates for RNase H. Bioorg Med Chem Lett. 2001;11(19):2623–2626.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yao X, Sun C, Fan B, et al. Neurotropin exerts neuroprotective effects after spinal cord injury by inhibiting apoptosis and modulating cytokines. J Orthop Translat. 2021;26:74–83.
   PubMed Web of Science ®Google Scholar
• Zhang DY, Yu K, Yang Z, et al. Variation in expression of small ubiquitin-like modifiers in injured sciatic nerve of mice. Neural Regen Res. 2019;14(8):1455–1461.
   PubMed Web of Science ®Google Scholar
• Meng J, Zhang Q, Yang C, et al. Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-kappaB. Front Pharmacol. 2019;10:365.
   PubMed Web of Science ®Google Scholar
• Yu C, Li P, Wang YX, et al. Sanguinarine attenuates neuropathic pain by inhibiting P38 MAPK activated neuroinflammation in rat model. Drug Des Devel Ther. 2020;14:4725–4733.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhao W, Zhao T, et al. S100A4 in spinal substantia gelatinosa from dorsal root ganglia modulates neuropathic pain in a rodent spinal nerve injury model. J Pain Res. 2021;14:665–679.
   PubMed Web of Science ®Google Scholar
• Hu Z, Yuan Y, Zhang X, et al. Human umbilical cord mesenchymal stem cell-derived exosomes attenuate oxygen-glucose deprivation/reperfusion-induced microglial pyroptosis by promoting foxo3a-dependent mitophagy. Oxid Med Cell Longev. 2021;2021:6219715.
   PubMed Web of Science ®Google Scholar
• Ye H, Li W, Wu K, et al. The SP1-induced long noncoding RNA, LINC00339, promotes tumorigenesis in colorectal cancer via the miR-378a-3p/MED19 axis. Onco Targets Ther. 2020;13:11711–11724.
   PubMed Web of Science ®Google Scholar
• Dai XJ, Li N, Yu L, et al. Activation of BV2 microglia by lipopolysaccharide triggers an inflammatory reaction in PC12 cell apoptosis through a toll-like receptor 4-dependent pathway. Cell Stress Chaperones. 2015;20(2):321–331.
   PubMed Web of Science ®Google Scholar
• van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662.
   PubMed Web of Science ®Google Scholar
• Allen HN, Bobnar HJ, Kolber BJ. Left and right hemispheric lateralization of the amygdala in pain. Prog Neurobiol. 2021;196:101891.
   PubMed Web of Science ®Google Scholar
• Karu K, Swanwick RS, Novejarque-Gadea A, et al. Quantitative proteomic analysis of the central amygdala in neuropathic pain model rats. J Proteome Res. 2020;19(4):1592–1619.
   PubMed Web of Science ®Google Scholar
• Wood J, Verma D, Lach G, et al. Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala. Brain Struct Funct. 2016;221(7):3373–3391.
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Zoicas I. Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors. J Psychopharmacol. 2019;33(12):1533–1539.
   PubMed Web of Science ®Google Scholar
• Carrasco C, Naziroglu M, Rodriguez AB, et al. Neuropathic Pain: delving into the oxidative origin and the possible implication of transient receptor potential channels. Front Physiol. 2018;9:95.
   PubMed Web of Science ®Google Scholar
• Kopsky DJ, Keppel Hesselink JM. Phenytoin cream for the treatment for neuropathic pain: case series. Pharmaceuticals (Basel). 2018;11(2):53.
   PubMedGoogle Scholar
• Karu K, Swanwick RS, Novejarque-Gadea A, et al. Quantitative proteomic analysis of the central Amygdala in neuropathic pain model rats. J Proteome Res. 2020;19(4):1592–1619.
   PubMed Web of Science ®Google Scholar
• Fendt M, Burki H, Imobersteg S, et al. Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect. Psychopharmacology (Berl). 2009;206(2):291–301.
   PubMed Web of Science ®Google Scholar
• Tracey DJ, Romm MA, Yao NN. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y. Brain Res. 1995;669(2):245–254.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu XY, Jiao Y, et al. NPY2R signaling gates spontaneous and mechanical, but not thermal, pain transmission. Mol Pain. 2019;15:1744806919887830.
   Web of Science ®Google Scholar
• Diaz-delcastillo M, Woldbye DPD, Heegaard AM. Neuropeptide Y and its Involvement in Chronic Pain. Neuroscience. 2018;387:162–169.
   PubMed Web of Science ®Google Scholar
• Xie W, Li F, Han Y, et al. Neuropeptides are associated with pain threshold and bone microstructure in ovariectomized rats. Neuropeptides. 2020;81:101995.
   PubMed Web of Science ®Google Scholar
• Fu W, Wessel CR, Taylor BK. Neuropeptide Y tonically inhibits an NMDARAC1TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain. Neuropeptides. 2020;80:102024.
   PubMed Web of Science ®Google Scholar
• Morales-Medina JC, Dumont Y, Benoit CE, et al. Role of neuropeptide Y Y(1) and Y(2) receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 2012;62(1):200–208.
   PubMed Web of Science ®Google Scholar
• Kostic S, Puljak L, Sapunar D. Attenuation of pain-related behaviour evoked by carrageenan injection through blockade of neuropeptide Y Y1 and Y2 receptors. Eur J Pain. 2013;17(4):493–504.
   PubMed Web of Science ®Google Scholar
• Coronel MF, Villar MJ, Brumovsky PR, et al. Spinal neuropeptide expression and neuropathic behavior in the acute and chronic phases after spinal cord injury: effects of progesterone administration. Peptides. 2017;88:189–195.
   PubMed Web of Science ®Google Scholar
• Schriemer D, Sribudiani Y, IJ A, et al. Regulators of gene expression in enteric neural crest cells are putative hirschsprung disease genes. Dev Biol. 2016;416(1):255–265.
   PubMed Web of Science ®Google Scholar
• He C, Zhang J, Gao S, et al. Molecular characterization of three NPY receptors (Y2, Y5 and Y7) in chickens: gene structure, tissue expression, promoter identification, and functional analysis. Gen Comp Endocrinol. 2016;236:24–34.
   PubMed Web of Science ®Google Scholar
• Choi DC, Lee JY, Lim EJ, et al. Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats. Exp Neurol. 2012;236(2):268–282.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun J, Yang B, et al. Therapeutic effect of tetrapanax papyriferus and hederagenin on chronic neuropathic pain of chronic constriction injury of sciatic nerve rats based on kegg pathway prediction and experimental verification. Evid Based Complement Alternat Med. 2020;2020:2545806.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L, Wang J, et al. Paeoniflorin and albiflorin attenuate neuropathic pain via MAPK pathway in chronic constriction injury rats. Evid Based Complement Alternat Med. 2016;2016:8082753.
   PubMed Web of Science ®Google Scholar